Investing.com - Avita Medical (NASDAQ:RCEL) reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Avita Medical announced earnings per share of $-0.48 on revenue of $5.1M. Analysts polled by Investing.com anticipated EPS of $-0.27 on revenue of $5.48M.
Avita Medical shares are down 50.9% from the beginning of the year, still down 59.64% from its 52 week high of $55.35 set on February 19. They are under-performing the Nasdaq which is up 28.77% from the start of the year.
Avita Medical follows other major Healthcare sector earnings this month
Avita Medical's report follows an earnings beat by J&J on October 13, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on October 27 with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.71 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar